Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on assets.
The trailing-twelve-month return on assets at AMAG Pharmaceuticals, Inc. AMAG is 19.90 percent. AMAG Pharmaceuticals' revenue for the same period is $124.40 million.
The trailing-twelve-month return on assets at Meridian Bioscience, Inc. VIVO is 19.70 percent. Meridian Bioscience's PEG ratio is 1.33.
The trailing-twelve-month return on assets at SurModics, Inc. SRDX is 12.40 percent. SurModics' EPS for the same period is $0.89.
The trailing-twelve-month return on assets at Neogen Corporation NEOG is 8.80 percent. Neogen's profit margin for the same period is 11.70 percent.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in